SCHEMBL29361679

SCHEMBL29361679

CC(C)(C)CCN1CCC2(CC1)CC2NC(=O)c1cccc(C#N)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 3/20 0.44
▸ CACNA1I Q9P0X4 2/20 0.44
▸ OPRM1 P35372 1/20 0.41
▸ OPRD1 P41143 1/20 0.41
▸ OPRK1 P41145 1/20 0.41
▸ DRD4 P21917 1/20 0.41
▸ CHRM3 P20309 1/20 0.40
▸ ROCK2 O75116 1/20 0.40
▸ CCR5 P51681 1/20 0.39
▸ CCKBR P32239 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ NAMPT P43490 1/20 0.38
▸ ACKR3 P25106 1/20 0.38
▸ DRD2 P14416 1/20 0.38
▸ DRD3 P35462 1/20 0.38
▸ GSK3B P49841 1/20 0.38
▸ VNN1 O95497 1/20 0.38
▸ GPR139 Q6DWJ6 1/20 0.38
▸ RORC P51449 1/20 0.38
▸ GRM5 P41594 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18838355 1.00 KCNH2 (0.44) KCNH2CACNA1IOPRM1OPRD1OPRK1
SCHEMBL18859676 0.90 KCNH2 (0.44) KCNH2CACNA1INAMPTDRD2DRD3
SCHEMBL18838392 0.85 KCNH2 (0.61) KCNH2CACNA1IL3MBTL1GRM5
SCHEMBL29363863 0.85 KCNH2 (0.61) KCNH2CACNA1IL3MBTL1GRM5
SCHEMBL18838368 0.85 CARM1 (0.46) KCNH2CACNA1IOPRM1
SCHEMBL18838388 0.84 KCNH2 (0.46) KCNH2CACNA1IOPRM1OPRD1OPRK1
SCHEMBL18838353 0.83 KCNH2 (0.48) KCNH2CACNA1IOPRM1
SCHEMBL29364658 0.80 KCNH2 (0.60) KCNH2CACNA1IOPRM1OPRD1OPRK1
SCHEMBL18838420 0.80 KCNH2 (0.60) KCNH2CACNA1IOPRM1OPRD1OPRK1
SCHEMBL18838485 0.79 KCNH2 (0.47) KCNH2CACNA1INAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108289886-B Ion channel inhibiting compounds, pharmaceutical formulations and uses 安华赛公司 2022-01-28 — — CN disclosed
Send feedback